Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development
MLL-AF4+ infant B cell acute lymphoblastic leukemia is characterized by an early onset and dismal survival. It initiates before birth, and very little is known about the early stages of the disease’s development. Using a conditional Mll-AF4-expressing mouse model in which fusion expression is target...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-07-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124716308002 |
id |
doaj-6876b78c7636415d93054bf2cab58c7a |
---|---|
record_format |
Article |
spelling |
doaj-6876b78c7636415d93054bf2cab58c7a2020-11-25T01:13:26ZengElsevierCell Reports2211-12472016-07-011641039105410.1016/j.celrep.2016.06.046Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in DevelopmentNeil A. Barrett0Camille Malouf1Chrysa Kapeni2Wendi A. Bacon3George Giotopoulos4Sten Eirik W. Jacobsen5Brian J. Huntly6Katrin Ottersbach7Department of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKHaematopoietic Stem Cell Biology Laboratory, MRC Molecular Haematology Unit, Weatherall Institute for Molecular Medicine, University of Oxford, Oxford OX3 9DS, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKMLL-AF4+ infant B cell acute lymphoblastic leukemia is characterized by an early onset and dismal survival. It initiates before birth, and very little is known about the early stages of the disease’s development. Using a conditional Mll-AF4-expressing mouse model in which fusion expression is targeted to the earliest definitive hematopoietic cells generated in the mouse embryo, we demonstrate that Mll-AF4 imparts enhanced B lymphoid potential and increases repopulation and self-renewal capacity during a putative pre-leukemic state. This occurs between embryonic days 12 and 14 and manifests itself most strongly in the lymphoid-primed multipotent progenitor population, thus pointing to a window of opportunity and a potential cell of origin. However, this state alone is insufficient to generate disease, with the mice succumbing to B cell lymphomas only after a long latency. Future analysis of the molecular details of this pre-leukemic state will shed light on additional events required for progression to acute leukemia.http://www.sciencedirect.com/science/article/pii/S2211124716308002 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Neil A. Barrett Camille Malouf Chrysa Kapeni Wendi A. Bacon George Giotopoulos Sten Eirik W. Jacobsen Brian J. Huntly Katrin Ottersbach |
spellingShingle |
Neil A. Barrett Camille Malouf Chrysa Kapeni Wendi A. Bacon George Giotopoulos Sten Eirik W. Jacobsen Brian J. Huntly Katrin Ottersbach Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development Cell Reports |
author_facet |
Neil A. Barrett Camille Malouf Chrysa Kapeni Wendi A. Bacon George Giotopoulos Sten Eirik W. Jacobsen Brian J. Huntly Katrin Ottersbach |
author_sort |
Neil A. Barrett |
title |
Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development |
title_short |
Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development |
title_full |
Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development |
title_fullStr |
Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development |
title_full_unstemmed |
Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development |
title_sort |
mll-af4 confers enhanced self-renewal and lymphoid potential during a restricted window in development |
publisher |
Elsevier |
series |
Cell Reports |
issn |
2211-1247 |
publishDate |
2016-07-01 |
description |
MLL-AF4+ infant B cell acute lymphoblastic leukemia is characterized by an early onset and dismal survival. It initiates before birth, and very little is known about the early stages of the disease’s development. Using a conditional Mll-AF4-expressing mouse model in which fusion expression is targeted to the earliest definitive hematopoietic cells generated in the mouse embryo, we demonstrate that Mll-AF4 imparts enhanced B lymphoid potential and increases repopulation and self-renewal capacity during a putative pre-leukemic state. This occurs between embryonic days 12 and 14 and manifests itself most strongly in the lymphoid-primed multipotent progenitor population, thus pointing to a window of opportunity and a potential cell of origin. However, this state alone is insufficient to generate disease, with the mice succumbing to B cell lymphomas only after a long latency. Future analysis of the molecular details of this pre-leukemic state will shed light on additional events required for progression to acute leukemia. |
url |
http://www.sciencedirect.com/science/article/pii/S2211124716308002 |
work_keys_str_mv |
AT neilabarrett mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment AT camillemalouf mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment AT chrysakapeni mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment AT wendiabacon mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment AT georgegiotopoulos mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment AT steneirikwjacobsen mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment AT brianjhuntly mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment AT katrinottersbach mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment |
_version_ |
1725162335465635840 |